Biohaven Reports New Clinical Data in Epilepsy with Opakalim, a Selective Kv7.2/7.3 Activator, Highlighting Seizure Control and Markedly Differentiated Tolerability Profile
Go back to Biohaven Reports New Clinical Data in Epilepsy with Opakalim, a Selective Kv7.2/7.3 Activator, Highlighting Seizure Control and Markedly Differentiated Tolerability Profile| (NYSE: BHVN) | Delayed: 11.28 -0.09 (0.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.37 | 52 Week High | $ | |||
| Open | $11.43 | 52 Week Low | $ | |||
| Day High | $11.99 | P/E | N/A | |||
| Day Low | $11.26 | EPS | $ | |||
| Volume | 2,361,335 | |||||
